MedPath

L-carnitine for Fatigue in COPD

Phase 2
Completed
Conditions
Copd
Fatigue
Interventions
Dietary Supplement: L-carnitine 1000 mg twice daily
Dietary Supplement: Placebo capsules
Behavioral: Weekly health coaching calls
Registration Number
NCT03008356
Lead Sponsor
Mayo Clinic
Brief Summary

supplementation with L-carnitine that is available both as an FDA-approved therapy for primary carnitine deficiency, as well as widely available as an over-the-counter ergogenic aid will improve wellbeing and function measured by questionnaires in patient with chronic obstructive pulmonary disease (COPD).

based on our review of literature that addition of health coaching (HC) to L-carnitine will yield greater gains.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
33
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
L-carnitineL-carnitine 1000 mg twice dailyOral L-carnitine 1000mg twice daily
L-carnitine + health coachingWeekly health coaching callsOral L-carnitine 1000mg twice daily and weekly 10-15 minute health coaching calls
L-carnitine + health coachingL-carnitine 1000 mg twice dailyOral L-carnitine 1000mg twice daily and weekly 10-15 minute health coaching calls
PlaceboPlacebo capsulesPlacebo capsules twice daily
Primary Outcome Measures
NameTimeMethod
Change in Exercise Capacity as Measured by the Six Minute Walk Test (6MWT)baseline, end of 8 week intervention

The 6MWT is a widely studied, standardized and widely utilized test that evaluates the global and integrated responses of all the systems involved during exercise, including the pulmonary and cardiovascular systems, systemic circulation, peripheral circulation, blood, neuromuscular units, and muscle metabolism. The self-paced 6MWT assesses the submaximal level of functional capacity. Most patients do not achieve maximal exercise capacity during the 6MWT; instead, they choose their own intensity of exercise and are allowed to stop and rest during the test.

Secondary Outcome Measures
NameTimeMethod
Change in Physical Fatigue as Measured by the Chalder Fatigue Questionnaire (CFQ-11)baseline, end of 8 week intervention

The CFQ-11 is a well-known, widely utilized and validated self-administered questionnaire for measuring the extent and severity of fatigue. The scoring incorporates two self-assessment scales measuring components indicative of physical fatigue \[8 items\] and mental fatigue \[5 items\]. The 11 individual items are scored from 0 (better than usual) to 3 (much worse than usual); total score range: 0-33.

Change in Health-Related Quality of Life as Measured by the Chronic Respiratory Questionnaire (CRQ)baseline, end of 8 week intervention

The CRQ is a widely utilized and validated interviewer-administered questionnaire measuring both physical and emotional aspects of chronic respiratory disease. There are 20 questions, with each item graded on 7-point Likert scale. Scores can range from 20 to 100. Higher scores indicate better quality of life.

Physical Activity as Measured by the SenseWear Armbandend of 8 week intervention

The SenseWear Armband system (Temple Healthcare) is a versatile arm-band monitor allowing convenient and accurate collection of raw data regarding energy expenditure, sleep duration and quality, physical activity and movement in subjects in a free-living environment, allowing them to go about their normal daily activities. Patients will be shown how to wear the activity monitor and be asked to use it for at least 5 days for 23 hours a day. They will be provided instructions and pre-paid shipping materials for wear and return of the monitor.

Trial Locations

Locations (1)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath